Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Oxford Drug Design Ltd is a biotechnology company specializing in rapid and robust drug discovery powered by AI. They leverage their expertise in tRNA synthetase enzyme targeting and AI/Machine…

Oxford Drug Design Ltd is a biotechnology company specializing in rapid and robust drug discovery powered by AI. They leverage their expertise in tRNA synthetase enzyme targeting and AI/Machine…
Headquarters / origin: Oxford, UK; university spin-out
Focus: AI-powered small-molecule drug discovery (tRNA synthetase targeting); oncology and anti-infectives
Founded: 2001 (company origin) / 2017 (listed founded year in snapshot)
Team size: Approximately 11 employees (snapshot)
Funding (reported): Reported >$12M total; specific rounds include $1.9M (2017) and $2.7M bridge (2022)
Developing novel small-molecule therapeutics for cancer and infectious diseases by targeting tRNA synthetase enzymes and accelerating discovery via AI-driven computational methods.
2017
Biotechnology
1.9M
April 2017 financing supported by existing shareholders including IP Group plc and new investors
Reported securing over £8M in combined grant and equity including CARB-X awards and a UK DHSC SBRI award
2.7M
Bridge commitments from existing investors including ACF Investors, o2h Ventures, Jonathan Milner, returning angels and R42 Group
“Mix of grant and equity supporters including ACF Investors, o2h Ventures, CARB-X, UK Department of Health and Social Care (DHSC), PACE-AMR, R42 Group, Jonathan Milner”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,300+
New This Week